Marshall Wace’s Raptor Pharmaceutical RPTP Stock Holding History
Bought
Maintained
Sold
Other funds holding RPTP
Marshall Wace's RPTP Position: Q2 2016 in Review
Marshall Wace sold out of Raptor Pharmaceutical (RPTP) in Q2 2016, closing a stake of 386,825 shares — an estimated $1.78M sold.
Marshall Wace first reported a position in RPTP in Q2 2015 and held it in 2 quarters. The position peaked at $6.03M in Q2 2015. 93 funds tracked by Wall St. Rank hold RPTP as of Q2 2016.
- Marshall Wace reported no remaining Raptor Pharmaceutical position as of Q2 2016 after selling out during the quarter.
- Marshall Wace sold 386,825 Raptor Pharmaceutical shares in Q2 2016, an estimated $1.78M.
- Marshall Wace first reported a position in Raptor Pharmaceutical in Q2 2015 and held it in 2 quarters.
- Marshall Wace's Raptor Pharmaceutical position peaked at $6.03M in Q2 2015.
- 93 funds tracked by Wall St. Rank held Raptor Pharmaceutical as of Q2 2016.
Based on Marshall Wace's 13F filing for Q2 2016, filed 12 Aug 2016.